Search results
Siam Bioscience Group is a Thai company that produces high quality and affordable medicines for public health security and well-being. Learn about its history, products, services, corporate value, and social responsibility.
- Contact
Head office Siam Bioscience Apexcela 44 Srijulsup Tower,...
- Products & Services
Siam Bioscience Group aims to research, develop,...
- News
And pharmacist Dr. Suchart Chongprasert, Director of Drug...
- Contact
เครือสยามไบโอไซเอนซ์ เป็นบริษัทที่ผลิตยาและผลิตภัณฑ์เพื่อสุขภาพที่มีคุณภาพและมาตรฐานระดับโลก เพื่อความมั่นคงด้านสาธารณสุข และสุขภาพที่ดีของทุกคน เว็บไซต์นี้
Siam Bioscience Company, Ltd. (Thai: สยามไบโอไซเอนซ์) is a Thai drug manufacturer, owned by King Maha Vajiralongkorn.
Siam Bioscience Group aims to research, develop, manufacture, and commercialize medicines and wellness products to improve accessiblity, quality, and healthcare sustainability. Furthermore, we always collaborate with various organizations who shared our passion and mission to bring more high impact products to the market in the future.
Jun 2, 2021 · AstraZeneca announced the official launch of its supply chain in Thailand, with the first doses of locally produced COVID-19 vaccine ready to be gradually rolled out. The vaccine is manufactured by Siam Bioscience, a leading Thai biopharmaceutical company, in partnership with AstraZeneca.
Apr 28, 2021 · Siam Bioscience is critical to support AstraZeneca’s goal of creating and providing broad, equitable and timely access of this vaccine to Southeast Asia. This is the only facility dedicated to providing vaccines to eight other countries in the region.
Oct 14, 2021 · The Thai-produced AstraZeneca vaccine is recommended by the WHO for global emergency use after passing the review of Australia's TGA. Siam Bioscience is a subsidiary of the Crown Property Bureau that produces biopharmaceuticals for domestic and regional markets.
